FDA — authorised 2 November 2018
- Application: NDA209128
- Marketing authorisation holder: VERTICAL PHARMS
- Local brand name: DSUVIA
- Indication: TABLET — SUBLINGUAL
- Status: approved
🇺🇸 Sublingual Sufentanil in United States
FDA authorised Sublingual Sufentanil on 2 November 2018
Marketing authorisation
Other Pain Management approved in United States
Frequently asked questions
Is Sublingual Sufentanil approved in United States?
Yes. FDA authorised it on 2 November 2018.
Who is the marketing authorisation holder for Sublingual Sufentanil in United States?
VERTICAL PHARMS holds the US marketing authorisation.